期刊文献+

加强和规范综合医疗机构结核病预防性治疗工作

Strengthening and standardizing the preventive treatment for tuberculosis in comprehensive medical facilities
原文传递
导出
摘要 针对结核病发病高危人群开展预防性治疗是结核病防控工作的重要内容, 综合医疗机构承担着重要职能。本刊本期发表了《综合医疗机构结核病发病高危人群的预防性治疗专家共识》。该共识根据综合医疗机构涉及结核病发病高危人群的情况界定了预防性治疗目标人群, 针对不同人群推荐了预防性治疗时机和方案, 并对预防性治疗的管理提出了建议, 将有利于指导综合医疗机构不同学科更加规范的开展结核病预防性治疗工作。本文就该共识的形成背景和临床意义进行补充和探讨。 Preventive treatment of high-risk groups for tuberculosis is an important part of tuberculosis prevention and control strategies,and comprehensive medical facilities have an important role to play.This issue of the journal published the“Expert consensus on tuberculosis preventive treatment for individuals at high risk of developing active diseases from latent tuberculosis infection in comprehensive medical facilities”.The consensus defined the target population for tuberculosis preventive treatment,recommended the timing of treatment initiation and optional treatment regimens for different groups,and put forward suggestions for the management of preventive treatment.It helped to guide the comprehensive medical facilities to provide more standardized tuberculosis preventive treatment.This article discussed the background and clinical significance of the consensus.
作者 高磊 曹彬 Gao Lei;Cao Bin(National Institute of Pathogen Biology,Tuberculosis Research Center,Chinese Academy of Medical Sciences,Beijing 102629,China;National Respiratory Medicine Center,National Key Laboratory of Respiratory Diseases and Comorbidity,National Respiratory Disease Clinical Research Center,Institute of Respiratory Diseases,Chinese Academy of Medical Sciences,Respiratory Center,Department of Respiratory and Critical Care Medicine,China-Japan Friendship Hospital,Beijing 100029,China)
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2024年第10期906-908,共3页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 中国医学科学院医学与健康科技创新工程(2021-I2M-1-037)。
  • 相关文献

参考文献5

二级参考文献69

  • 1刘新,梁瑞霞.异烟肼与利福平联用预防结素强阳性人群发病的观察[J].中原医刊,2004,31(18):55-55. 被引量:3
  • 2Brassard P, Lowe AM, Bernatsky S, et al. Rheumatoid arthritis, its treatments, and the risk of tuberculosi in Quebec, Canada.Arthritis Rheum, 2009, 6t: 300-304.
  • 3Seong SS, Choi CB, Woo JH, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol, 2007, 34:706-711.
  • 4Carmona L, Hemandez-Gareia C, Vadillo C, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatoh 2003, 30: 1436-1439.
  • 5Gomez-Reino JJ, Cannona L, Valverde VR, et al. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multi- center active-surveillance report. Arthritis Rheum, 2003, 48: 2122-2127.
  • 6Brassard P, Kezouh A, Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis, 2006, 43: 717-722.
  • 7Chen DY, Shen GH, Lan JL, et al. Biphasic emergence of ac-tire tuberculosis in rheumatoid arthritis patients receiving TNF-ot inhibitors: the utility of IFN-T assay. Ann Rheum Dis, 2012, 71 : 231-237.
  • 8Singh JA, Furst DE, Bharat A, et 81. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hobo- ken), 2012, 64: 625-639.
  • 9Chen DY, Shen GH, Hsieh TY, et al. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum, 2008, 59: 800-806.
  • 10Miyasaka N, Takeuchi T, Eguchi K. Gyidelines for the proper use of etanercept in Japan. Mod Rheumatol, 2006, 16: 63-67.

共引文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部